In your practice, what premedications do you use for subcutaneous daratumumab?
What pre-medications do you administer with subcutaneous daratumumab?
Join Mednetto vote and see how they answered.
We administer the following pre-infusion medications 1 hour to 3 hours before the first 4 SQ infusions, and then we drop all premedications (except for dexamethasone) thereafter:
- Dexamethasone 20-40 mg
- Acetaminophen 650 mg
- Diphenhydramine 25 mg
- Montelukast 10 mg [this is not in the package insert but we have found it to be particularly helpful, especially with C1D1].
Join for free or sign in to see the full answer
I agree 99.9% with @Dr. First Last's excellent answer, with the exception of how long the dexamethasone is truly required; nothing new since we've discussed this before via Twitter. His group has published on their experience (see my comment on his answer), which has been very helpful here!
As a rationale for stopping dexamethasone after 2 cycles with any CD38-containing regimen for all purposes, I often cite both the IFM 2017-03 trial and the REST trial. Both stopped the dexamethasone for all purposes (including as a pre-medication and also for any potential myeloma control) after 8 weeks.
- IFM 2017-03 (Dara-Rd → Dara-R): Manier et al., PMID 41038184
- REST (Isa-VRd → Isa-VR): Askeland et al., PMID 39909655
So we also similarly drop all pre-me...
Join for free or sign in to see the full answer